OppenheimerFunds’s MiMedx Group MDXG Stock Holding History

OppenheimerFunds’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-42,619	Closed	-$263K	–	1838
2018 Q3	$263K	Buy	42,619 +10,946	+35%	+$49.5K	﹤0.01%	1700
2018 Q2	$202K	Buy	31,673 +5,215	+20%	+$37.1K	﹤0.01%	1771
2018 Q1	$184K	Buy	26,458 +10,676	+68%	+$124K	﹤0.01%	1744
2017 Q4	$199K	Sell	15,782 -185	-1%	-$2.26K	﹤0.01%	1811
2017 Q3	$190K	Buy	15,967 +951	+6%	+$14.1K	﹤0.01%	1818
2017 Q2	$225K	Sell	15,016 -7,844	-34%	-$105K	﹤0.01%	1783
2017 Q1	$217K	Buy	22,860 +7,112	+45%	+$60.1K	﹤0.01%	1810
2016 Q4	$140K	Buy	15,748 +4,710	+43%	+$42.3K	﹤0.01%	1760
2016 Q3	$95K	Sell	11,038 -879	-7%	-$6.96K	﹤0.01%	1710
2016 Q2	$95K	Buy	+11,917	New	+$92.7K	﹤0.01%	1673
2016 Q1	–	Sell	-10,504	Closed	-$98K	–	1719
2015 Q4	$98K	Buy	+10,504	New	+$91K	﹤0.01%	1719

Other funds holding MDXG

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

TIM

Thompson Investment Management Madison, Wisconsin $872M AUM 35.59% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

WMC

Westwood Management Corporation Chicago, Illinois $270M AUM 54.59% 1-Year Est. Return

PAM

Pegasus Asset Management Montebello, New York $313M AUM 24.74% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

OppenheimerFunds's MDXG Position: Q4 2018 in Review

OppenheimerFunds sold out of MiMedx Group (MDXG) in Q4 2018, closing a stake of 42,619 shares — an estimated $263K sold.

OppenheimerFunds first reported a position in MDXG in Q4 2015 and held it in 11 quarters. The position peaked at $263K in Q3 2018. 38 funds tracked by Wall St. Rank hold MDXG as of Q4 2018.

OppenheimerFunds reported no remaining MiMedx Group position as of Q4 2018 after selling out during the quarter.
OppenheimerFunds sold 42,619 MiMedx Group shares in Q4 2018, an estimated $263K.
OppenheimerFunds first reported a position in MiMedx Group in Q4 2015 and held it in 11 quarters.
OppenheimerFunds's MiMedx Group position peaked at $263K in Q3 2018.
38 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2018.

Based on OppenheimerFunds's 13F filing for Q4 2018, filed 11 Feb 2019.